ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
74 hedge funds and large institutions have $298M invested in Albireo Pharma, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 6 closing their positions.
Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
29
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Federated Hermes
Pittsburgh,
Pennsylvania
|
$46.3M |
| 2 |
2
Man Group
London,
United Kingdom
|
$6.11M |
| 3 |
3
BlackRock
New York
|
$21.2M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$6.72M |
| 5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$1.21M |
